These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36263620)

  • 1. uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review).
    Wang L; Lin X; Sun P
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.
    Zhai BT; Tian H; Sun J; Zou JB; Zhang XF; Cheng JX; Shi YJ; Fan Y; Guo DY
    J Transl Med; 2022 Mar; 20(1):135. PubMed ID: 35303878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of urokinase receptor in tumor progression and development.
    Noh H; Hong S; Huang S
    Theranostics; 2013; 3(7):487-95. PubMed ID: 23843896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy.
    Li D; Liu S; Shan H; Conti P; Li Z
    Theranostics; 2013; 3(7):507-15. PubMed ID: 23843898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy.
    Lund IK; Illemann M; Thurison T; Christensen IJ; Høyer-Hansen G
    Curr Drug Targets; 2011 Nov; 12(12):1744-60. PubMed ID: 21707477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
    Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
    Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
    Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
    Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia Promotes Extravillous Trophoblast Cell Invasion through the Hypoxia-Inducible Factor Urokinase-Type Plasminogen Activator Receptor Pathway.
    Shigemitsu A; Naruse K; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(3-4):232-241. PubMed ID: 35785760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
    Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
    J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single target.
    O'Halloran TV; Ahn R; Hankins P; Swindell E; Mazar AP
    Theranostics; 2013; 3(7):496-506. PubMed ID: 23843897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
    Santibanez JF; Krstic J
    Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
    Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.